BOF A1, with the CAS number 103767-48-2, is a chemical substance that is primarily recognized for its application in various industrial processes, particularly in the field of materials science and chemical manufacturing. It is characterized by its unique molecular structure, which contributes to its specific reactivity and stability under various conditions. The substance may exhibit properties such as solubility in certain solvents, thermal stability, and a defined range of melting and boiling points, making it suitable for specific applications. Additionally, BOF A1 may possess functional groups that impart particular chemical behaviors, such as reactivity with other compounds or catalytic properties. Safety data sheets typically highlight its handling precautions, potential hazards, and environmental impact, emphasizing the importance of proper safety measures during its use. Overall, BOF A1 is a specialized chemical that plays a significant role in its designated applications, necessitating a thorough understanding of its properties for effective and safe utilization.

BOF A1

103767-48-2: 3-(3-(6-Benzoyloxy-3-cyano-2-pyridyloxycarbonyl)benzoyl)-3'-O-benzyl-2'-deoxy-5-fluorouridine, Benzoic acid, 3-((3-(2-deoxy-3-O-(phenylmethyl)-beta-D-erythro-pentofuranosyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl)carbonyl)-, 6-(benzoyloxy)-3-cyano-2-pyridinyl ester, 3-[3-({[6-(benzoyloxy)-3-cyanopyridin-2-yl]oxy}carbonyl)benzoyl]-3'-O-benzyl-2'-deoxy-5-fluorouridine, Bof A1,  Bof-A1

Fluorouracil is a pyrimidine-based chemotherapy drug that inhibits DNA synthesis by inhibiting the activity of the enzyme thymidylate synthase, thereby preventing the production of thymine nucleotides. Fluorouracil is used to treat cancers such as colorectal cancer and breast cancer. It is also used as adjuvant therapy for head and neck cancer. Fluorouracil works by binding to the enzyme dihydrofolate reductase, which is required for the synthesis of DNA precursors. This binding prevents the formation of tetrahydrofolate, which is essential for cell division. The main side effects are myelosuppression and gastrointestinal toxicities, which can be reduced or prevented with appropriate doses (lowering dose) or discontinuation (in case of gastrointestinal toxicity).

CAS 103767-48-2: BOF A1

3-(3-(6-Benzoyloxy-3-cyano-2-pyridyloxycarbonyl)benzoyl)-3'-O-benzyl-2'-deoxy-5-fluorouridine

Ref: 3D-FB101960